1. Home
  2. BJDX vs GNLN Comparison

BJDX vs GNLN Comparison

Compare BJDX & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • GNLN
  • Stock Information
  • Founded
  • BJDX 2015
  • GNLN 2005
  • Country
  • BJDX United States
  • GNLN United States
  • Employees
  • BJDX N/A
  • GNLN N/A
  • Industry
  • BJDX Medical Specialities
  • GNLN Durable Goods
  • Sector
  • BJDX Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • BJDX Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • BJDX 2.2M
  • GNLN 2.3M
  • IPO Year
  • BJDX 2021
  • GNLN 2019
  • Fundamental
  • Price
  • BJDX $1.67
  • GNLN $0.01
  • Analyst Decision
  • BJDX
  • GNLN
  • Analyst Count
  • BJDX 0
  • GNLN 0
  • Target Price
  • BJDX N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • BJDX 3.4M
  • GNLN 39.7M
  • Earning Date
  • BJDX 05-14-2025
  • GNLN 03-21-2025
  • Dividend Yield
  • BJDX N/A
  • GNLN N/A
  • EPS Growth
  • BJDX N/A
  • GNLN N/A
  • EPS
  • BJDX N/A
  • GNLN N/A
  • Revenue
  • BJDX N/A
  • GNLN $13,275,000.00
  • Revenue This Year
  • BJDX N/A
  • GNLN $1,541.21
  • Revenue Next Year
  • BJDX $55.56
  • GNLN N/A
  • P/E Ratio
  • BJDX N/A
  • GNLN N/A
  • Revenue Growth
  • BJDX N/A
  • GNLN N/A
  • 52 Week Low
  • BJDX $1.48
  • GNLN $0.01
  • 52 Week High
  • BJDX $316.80
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 38.27
  • GNLN 18.47
  • Support Level
  • BJDX $1.46
  • GNLN $0.21
  • Resistance Level
  • BJDX $3.60
  • GNLN $0.29
  • Average True Range (ATR)
  • BJDX 0.63
  • GNLN 0.03
  • MACD
  • BJDX -0.13
  • GNLN -0.00
  • Stochastic Oscillator
  • BJDX 2.40
  • GNLN 0.32

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: